Pan-tumor Validation of a NGS Fraction-Based MSI Analysis As a Predictor of Response to Pembrolizumab
npj Precision Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined